Exabis Library
Welcome to the e-CCO Library!
P242: Latent Tuberculosis: frequency of occurrence and effect on clinical, laboratory, endoscopic and morphological activity of the course Inflammatory Bowel Diseases
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P242: Newly diagnosed Inflammatory Bowel Disease patients referred via the Straight To Test Lower GI two week wait pathway, Single Centre Study.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P242: Performance of the BÜHLMANN Quantum Blue® Infliximab point-of-care assay dedicated for therapeutic drug monitoring of serum infliximab trough levels
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P242: Phenotypic characterisation of elderly – onset inflammatory bowel disease – IBD at the extremes
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P242: The prevalence of sarcopenia and its effect on prognosis in patients with Crohn’s disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P242: Universal exclusion of patients with Permanent Ileostomy in Crohn's disease clinical trials: A systematic review
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P243 Changes in the therapeutic management of inflammatory bowel disease in the biological era – a nationwide retrospective cohort study in three Nordic countries: Results from the TRINordic study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P243: Colectomy rates in ulcerative colitis are low and decreasing: Ten-year follow-up data from the Swiss IBD cohort study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P243: Complications of newly diagnosed Crohn's disease can be predicted by mathematical modeling of serologic responses
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P243: Developing a protocol to conduct a student-driven study across Europe: EuroSurg-1 study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P243: Elevated presepsin levels are a marker of sepsis risk in patients with inflammatory bowel diseases receiving therapy of TNF-α blockers.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P243: Relationship between intestinal ultrasound, fecal calprotectin and Harvey-Bradshaw Index in the assessment of infllamatory activity in Cronh´s Disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P243: The association between serological markers ASCA and ANCA and response to induction treatment in therapy-naïve children with inflammatory bowel disease: an international prospective study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P243: The different role of histology in ulcerative colitis and Crohn’s disease: a retrospective study in a single referral centre
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P244 Validation of the Red Flags index for early diagnosis of Crohn’s disease: A prospective general practitioner study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P244: Clinician preferences in treating steroid resistant ulcerative colitis: a discrete-choice experiment (DCE) survey
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P244: COVID-19 vaccine does not increase the likelihood of disease exacerbation in IBD: results from a population-based study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P244: Diffusion-weighted MRI enables to accurately grade inflammatory activity in patients of ileocolonic Crohn's disease: results from an observational study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P244: Faecal calprotectin is a very reliable tool to predict and monitor the risk of relapse after therapeutic de-escalation in patients with inflammatory bowel diseases
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P244: Is prognostic utility of rapid faecal calprotectin test equal in all inflammatory bowel disease (IBD) subtypes? Retrospective analysis based on endoscopic indices
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM